Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
5.27
+0.05 (0.96%)
At close: Apr 28, 2026, 4:00 PM EDT
5.31
+0.04 (0.76%)
After-hours: Apr 28, 2026, 5:36 PM EDT
Evolus Market Cap
Evolus has a market cap or net worth of $342.87 million as of April 28, 2026. Its market cap has decreased by -43.48% in one year.
Market Cap
342.87M
Enterprise Value
444.04M
1-Year Change
-43.48%
Ranking
Category
Stock Price
$5.27
Market Cap Chart
Since February 8, 2018, Evolus's market cap has increased from $271.30M to $342.87M, an increase of 26.38%. That is a compound annual growth rate of 2.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 342.90M | -20.46% |
| Dec 31, 2025 | 431.10M | -38.34% |
| Dec 31, 2024 | 699.10M | 16.17% |
| Dec 29, 2023 | 601.80M | 42.47% |
| Dec 30, 2022 | 422.40M | 16.75% |
| Dec 31, 2021 | 361.80M | 219.05% |
| Dec 31, 2020 | 113.40M | -66.03% |
| Dec 31, 2019 | 333.80M | 2.83% |
| Dec 31, 2018 | 324.60M | 19.65% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aquestive Therapeutics | 499.16M |
| Esperion Therapeutics | 491.64M |
| Kamada | 474.62M |
| Canopy Growth | 439.92M |
| Emergent BioSolutions | 425.03M |
| Akebia Therapeutics | 380.42M |
| SIGA Technologies | 328.85M |
| Organogenesis Holdings | 308.74M |